Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other 2Head & Neck 2Gastrointestinal 1

Conditions

Breast Neoplasms 2767Carcinoma, Non-Small-Cell Lung 2265Prostatic Neoplasms 1427Colorectal Neoplasms 1295Neoplasms 1260Multiple Myeloma 1086Lung Neoplasms 1049Neoplasm Metastasis 995Leukemia, Myeloid, Acute 985Lymphoma 900Melanoma 864Pancreatic Neoplasms 818Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 753Recurrence 753Leukemia 733Lymphoma, Non-Hodgkin 684Leukemia, Lymphocytic, Chronic, B-Cell 665Squamous Cell Carcinoma of Head and Neck 618Lymphoma, Large B-Cell, Diffuse 617Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 598Brain Neoplasms 593Carcinoma, Renal Cell 587Glioblastoma 573Rectal Neoplasms 565Sarcoma 523Myelodysplastic Syndromes 522Lymphoma, Follicular 516

Interventions

FGF20 protein, human 2golotimod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Mouth Diseases × Clear all
NCT00323518 2016-04-13

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Celldex Therapeutics

Phase 2 Completed
390 enrolled

Mouth Diseases, Stomatitis

NCT00104065 2016-03-15

Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant

Celldex Therapeutics

Phase 2 Completed

Mouth Diseases, Stomatitis

NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

SciClone Pharmaceuticals

Phase 2 Unknown
160 enrolled
GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

NCT00230191 2007-01-15

Safety and Efficacy of RK0202 in Oral Mucositis

RxKinetix

Phase 2 Completed
110 enrolled
Head & NeckOther

Head and Neck Neoplasms, Mouth Diseases, Stomatitis, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡